New York Blood Center Enterprises (NYBCe) has broken ground on a 187,000-square-foot campus located at 601 Midland Ave. in Rye, New York. The facility will be home to NYBCe’s tri-state operations, including space for life sciences research, blood collections, processing and cell therapy manufacturing.
The Rye campus is expected to be finished in mid to late 2024 and will be the first-ever single campus for NYBCe. NYBCe’s research arm, the Lindsley F. Kimball Research Institute (LFKRI), has advanced numerous groundbreaking innovations in clinical care and biotechnology.
“We are grateful to the Town of Rye and all of the community members and elected officials who joined us for today’s special event,” said Christopher D. Hillyer, MD, president and CEO of New York Blood Center Enterprises. “We will transform the building into a state-of-the-art, multipurpose campus dedicated to life sciences research, blood collections, processing, distribution, specialty laboratories and cell therapy manufacturing to support the public health of our region and fulfill our mission to provide life-saving healthcare across the globe.
NYBCe was joined by New York State Assemblymember Steve Otis; Rye Mayor Josh Cohen; Rye City Manager Greg Usry; Deborah Novick, director of the Westchester County Executive’s Office; Consigli Construction Co.; G3 Architecture Interiors Planning and George Comfort & Sons for the press conference and official groundbreaking event that marked the start of construction at the campus.
“Congratulations to New York Blood Center on their upcoming move that will enhance their national reputation for excellence in serving patients, hospitals, researchers, academia, and biomedical companies with their wide-ranging services and skill in scientific innovation,” Otis said. “The new Rye campus is perfectly situated to serve the tri-state area, while also bringing their dynamic programs together at one location. The New York Blood Center’s role will grow even larger with the benefit of the new campus.”
